Emile Youssef

Dr. Youssef is a medical oncologist with extensive experience in medical research in academia and as a pharmaceutical and CRO executive. Before joining Tosk, he led early clinical development and proof of concept studies for Novartis, Eisai, Celgene, and Bayer. Dr. Youssef’s most recent positions were Vice President of Oncology/Hematology Scientific Solutions at Worldwide Clinical Trials, a clinical study management company, and Vice President and Head of Oncology at Oryn Therapeutics. He is a thought leader in oncology therapeutic development, publishing over 30 papers while holding hematology and oncology society memberships in the US, Europe, and Japan. Dr. Youssef completed his post-doctoral training at MD Anderson Cancer Center and holds a PhD in Molecular Oncology, a Surgical Oncology Diploma from Osaka City University, and a Doctor of Medicine (MB, Bch) from Cairo University.